Fact CheckerSign in

NCT07804537Not yet recruiting

Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Healthy Individuals

Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes

Source: ClinicalTrials.gov · Last updated 4 Sept 2026

Brief summary (registry, in English)

To study the effect of a re-ascent to high altitude (Quito Ecuador: 2850m) after a one-week stay at sea level (after prior descent from 2850m) on lung function and pulmonary resistance/reactance in healthy individuals, who live permanently \> 2600m.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
14 (estimated)
First submitted
17 Aug 2026
Start date
Sept 2026
Primary completion date
Oct 2026
Lead sponsor
Silvia Ulrich Somaini
NCT number
NCT07804537

What you commit to

  • Study type: Interventional
  • Planned participants: 14
  • From Sept 2026 to the primary completion date, Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • any self-perceived cardiopulmonary disease limiting daily activities

Age

  • Age \<18 years or \>80 years

Other

  • Participants who cannot follow the study investigations
  • Participants permanently living \< 2600m
  • Participants who traveled and stayed overnight at altitudes \<2000 m in the past 4 weeks.

Who the study is looking for

  • Adults aged 18-80 years and of all genders
  • Permanent residence \> 2600 m
  • healthy: no self perceived cardiopulmonary disease limiting daily activities
  • written informed consent to participate in the study.

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital of Zurich
Coordinator of this site? Confirm its status
ZurichSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.